Resverlogix CEO Discusses Phase 3 BETonMACE Clinical Trial

18:45 EDT 17 May 2018 | Investing News Network

Aside from the recent funding and Phase 3 trial news, Resverlogix has many milestones for investors to look forward to this year.

The post Resverlogix CEO Discusses Phase 3 BETonMACE Clinical Trial appeared first on Investing News Network.

Original Article: Resverlogix CEO Discusses Phase 3 BETonMACE Clinical Trial

More From BioPortfolio on "Resverlogix CEO Discusses Phase 3 BETonMACE Clinical Trial"